STACY LONG: Open Payments
NPI 1205906591 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 53 payments from 13 companies in 2025. Trend: 2023 $2,912 · 2024 $2,191 · 2025 $1,087
Food & beverage: $1,087
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 13 | $248 |
| ABBVIE INC. | 10 | $172 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $150 |
| Medtronic, Inc. | 3 | $116 |
| Averitas Pharma Inc. | 6 | $89 |
| Boston Scientific Corporation | 1 | $85 |
| PFIZER INC. | 3 | $51 |
| PROTEGA PHARMACEUTIALS INC | 1 | $48 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $38 |
| Lundbeck LLC | 2 | $36 |
Products named: RELISTOR, XTAMPZA, Belbuca, QUTENZA, Intracept, QULIPTA, OSTEOCOOL RF ABLATION SYSTEM, UBRELVY.
Industry payments across AZ — which companies pay providers there.
